{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:15Z","timestamp":1791928695919,"version":"4.3.4"},"reference-count":57,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"11","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,9,12]]},"DOI":"10.1167\/iovs.18-24931","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T15:39:32Z","timestamp":1536766772000},"page":"4558","source":"Crossref","is-referenced-by-count":24,"title":["Progression in X-linked Retinitis Pigmentosa Due to\n                    <i>ORF15-RPGR<\/i>\n                    Mutations: Assessment of Localized Vision Changes Over 2 Years"],"prefix":"10.1167","volume":"59","author":[{"given":"Artur V.","family":"Cideciyan","sequence":"first","affiliation":[{"name":"Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Charng","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro J.","family":"Roman","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sheplock","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra V.","family":"Garafalo","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Heon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G.","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-11-4558-b01","doi-asserted-by":"crossref","unstructured":"Guadagni V, Novelli E, Piano I, Gargini C, Strettoi E. Pharmacological approaches to retinitis pigmentosa: a laboratory perspective. Prog Retin Eye Res. 2015; 48: 62\u201381.","DOI":"10.1016\/j.preteyeres.2015.06.005"},{"key":"i1552-5783-59-11-4558-b02","doi-asserted-by":"crossref","unstructured":"Smith J, Ward D, Michaelides M, Moore AT, Simpson S. New and emerging technologies for the treatment of inherited retinal diseases: a horizon scanning review. Eye (Lond). 2015; 29: 1131\u20131140.","DOI":"10.1038\/eye.2015.115"},{"key":"i1552-5783-59-11-4558-b03","doi-asserted-by":"crossref","unstructured":"Thompson DA, Ali RR, Banin E, et al. Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium. Invest Ophthalmol Vis Sci. 2015; 56: 918\u2013931.","DOI":"10.1167\/iovs.14-16049"},{"key":"i1552-5783-59-11-4558-b04","doi-asserted-by":"crossref","unstructured":"Jacobson SG, Cideciyan AV. Treatment possibilities for retinitis pigmentosa. N Engl J Med. 2010; 363: 1669\u20131671.","DOI":"10.1056\/NEJMcibr1007685"},{"key":"i1552-5783-59-11-4558-b05","doi-asserted-by":"crossref","unstructured":"Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci U S A. 2005; 102: 6177\u20136182.","DOI":"10.1073\/pnas.0500646102"},{"key":"i1552-5783-59-11-4558-b06","doi-asserted-by":"crossref","unstructured":"Cideciyan AV, Jacobson SG, Beltran WA, et al. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci U S A. 2013; 110: E517\u2013E525.","DOI":"10.1073\/pnas.1218933110"},{"key":"i1552-5783-59-11-4558-b07","doi-asserted-by":"crossref","unstructured":"Jacobson SG, Cideciyan AV, Roman AJ, et al. Improvement and decline in vision with gene therapy in childhood blindness. N Engl J Med. 2015; 372: 1920\u20131926.","DOI":"10.1056\/NEJMoa1412965"},{"key":"i1552-5783-59-11-4558-b08","doi-asserted-by":"crossref","unstructured":"Jacobson SG, Voigt WJ, Parel JM, et al. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology. 1986; 93: 1604\u20131611.","DOI":"10.1016\/S0161-6420(86)33522-X"},{"key":"i1552-5783-59-11-4558-b09","doi-asserted-by":"crossref","unstructured":"Roman AJ, Schwartz SB, Aleman TS, et al. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures. Exp Eye Res. 2005; 80: 259\u2013272.","DOI":"10.1016\/j.exer.2004.09.008"},{"key":"i1552-5783-59-11-4558-b10","doi-asserted-by":"crossref","unstructured":"McGuigan DB III, Roman AJ, Cideciyan AV, et al. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa: filling a need to accommodate multicenter clinical trials. Invest Ophthalmol Vis Sci. 2016; 57: 3118\u20133128.","DOI":"10.1167\/iovs.16-19302"},{"key":"i1552-5783-59-11-4558-b11","doi-asserted-by":"crossref","unstructured":"Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A. 2008; 105: 15112\u201315117.","DOI":"10.1073\/pnas.0807027105"},{"key":"i1552-5783-59-11-4558-b12","doi-asserted-by":"crossref","unstructured":"Vervoort R, Lennon A, Bird AC, et al. Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet. 2000; 25: 462\u2013466.","DOI":"10.1038\/78182"},{"key":"i1552-5783-59-11-4558-b13","doi-asserted-by":"crossref","unstructured":"Branham K, Othman M, Brumm M, et al. Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease. Invest Ophthalmol Vis Sci. 2012; 53: 8232\u20138237.","DOI":"10.1167\/iovs.12-11025"},{"key":"i1552-5783-59-11-4558-b14","doi-asserted-by":"crossref","unstructured":"Churchill JD, Bowne SJ, Sullivan LS, et al. Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2013; 54: 1411\u20131416.","DOI":"10.1167\/iovs.12-11541"},{"key":"i1552-5783-59-11-4558-b15","doi-asserted-by":"crossref","unstructured":"Charng J, Cideciyan AV, Jacobson SG, et al. Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration. Hum Mol Genet. 2016; 25: 5444\u20135459.","DOI":"10.1093\/hmg\/ddw361"},{"key":"i1552-5783-59-11-4558-b16","doi-asserted-by":"crossref","unstructured":"Beltran WA, Cideciyan AV, Lewin AS, et al. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa. Proc Natl Acad Sci U S A. 2012; 109: 2132\u20132137.","DOI":"10.1073\/pnas.1118847109"},{"key":"i1552-5783-59-11-4558-b17","doi-asserted-by":"crossref","unstructured":"Beltran WA, Cideciyan AV, Iwabe S, et al. Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease. Proc Natl Acad Sci U S A. 2015; 112: E5844\u2013E5853.","DOI":"10.1073\/pnas.1509914112"},{"key":"i1552-5783-59-11-4558-b18","doi-asserted-by":"crossref","unstructured":"Wu Z, Hiriyanna S, Qian H, et al. A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration. Hum Mol Genet. 2015; 24: 3956\u20133970.","DOI":"10.1093\/hmg\/ddv134"},{"key":"i1552-5783-59-11-4558-b19","doi-asserted-by":"crossref","unstructured":"Pawlyk BS, Bulgakov OV, Sun X, et al. Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosa. Gene Ther. 2016; 23: 196\u2013204.","DOI":"10.1038\/gt.2015.93"},{"key":"i1552-5783-59-11-4558-b20","doi-asserted-by":"crossref","unstructured":"Beltran WA, Cideciyan AV, Boye SE, et al. Optimization of retinal gene therapy for X-linked retinitis pigmentosa due to RPGR mutations. Mol Ther. 2017; 25: 1866\u20131880.","DOI":"10.1016\/j.ymthe.2017.05.004"},{"key":"i1552-5783-59-11-4558-b21","unstructured":"Jacobson SG, Buraczynska M, Milam AH, et al. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene. Invest Ophthalmol Vis Sci. 1997; 38: 1983\u20131997."},{"key":"i1552-5783-59-11-4558-b22","doi-asserted-by":"crossref","unstructured":"Huang WC, Wright AF, Roman AJ, et al. RPGR-associated retinal degeneration in human X-linked RP and a murine model. Invest Ophthalmol Vis Sci. 2012; 53: 5594\u20135608.","DOI":"10.1167\/iovs.12-10070"},{"key":"i1552-5783-59-11-4558-b23","doi-asserted-by":"crossref","unstructured":"Luo X, Cideciyan AV, Iannaccone A, et al. Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials. PLoS One. 2015; 10: e0125700.","DOI":"10.1371\/journal.pone.0125700"},{"key":"i1552-5783-59-11-4558-b24","doi-asserted-by":"crossref","unstructured":"Zelinger L, Cideciyan AV, Kohl S, et al. Genetics and disease expression in the CNGA3 form of achromatopsia: steps on the path to gene therapy. Ophthalmology. 2015; 122: 997\u20131007.","DOI":"10.1016\/j.ophtha.2014.11.025"},{"key":"i1552-5783-59-11-4558-b25","doi-asserted-by":"crossref","unstructured":"Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999; 8: 135\u2013160.","DOI":"10.1177\/096228029900800204"},{"key":"i1552-5783-59-11-4558-b26","doi-asserted-by":"crossref","unstructured":"Fitzke FW, Crabb DP, McNaught AI, Edgar DF, Hitchings RA. Image processing of computerised visual field data. Br J Ophthalmol. 1995; 79: 207\u2013212.","DOI":"10.1136\/bjo.79.3.207"},{"key":"i1552-5783-59-11-4558-b27","doi-asserted-by":"crossref","unstructured":"Highman VN, Weale RA. Rhodopsin density and visual threshold in retinitis pigmentosa. Am J Ophthalmol. 1973; 75: 822\u2013832.","DOI":"10.1016\/0002-9394(73)90888-X"},{"key":"i1552-5783-59-11-4558-b28","unstructured":"Ripps H, Brin KP, Weale RA. Rhodopsin and visual threshold in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1978; 17: 735\u2013745."},{"key":"i1552-5783-59-11-4558-b29","unstructured":"Perlman I, Auerbach E. The relationship between visual sensitivity and rhodopsin density in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1981; 20: 758\u2013765."},{"key":"i1552-5783-59-11-4558-b30","unstructured":"Kemp CM, Faulkner DJ, Jacobson SG. Visual pigment levels in retinitis pigmentosa. Trans Ophthalmol Soc U K. 1983; 103 (Pt 4): 453\u2013457."},{"key":"i1552-5783-59-11-4558-b31","unstructured":"Kemp CM, Jacobson SG, Cideciyan AV, Kimura AE, Sheffield VC, Stone EM. RDS gene mutations causing retinitis pigmentosa or macular degeneration lead to the same abnormality in photoreceptor function. Invest Ophthalmol Vis Sci. 1994; 35: 3154\u20133162."},{"key":"i1552-5783-59-11-4558-b32","unstructured":"Jacobson SG, Kemp CM, Cideciyan AV, Macke JP, Sung CH, Nathans J. Phenotypes of stop codon and splice site rhodopsin mutations causing retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1994; 35: 2521\u20132534."},{"key":"i1552-5783-59-11-4558-b33","unstructured":"Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res. 1998; 17: 175\u2013205."},{"key":"i1552-5783-59-11-4558-b34","unstructured":"Machida S, Kondo M, Jamison JA, et al. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci. 2000; 41: 3200\u20133209."},{"key":"i1552-5783-59-11-4558-b35","doi-asserted-by":"crossref","unstructured":"Sadigh S, Cideciyan AV, Sumaroka A, et al. Abnormal thickening as well as thinning of the photoreceptor layer in intermediate age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013; 54: 1603\u20131612.","DOI":"10.1167\/iovs.12-11286"},{"key":"i1552-5783-59-11-4558-b36","doi-asserted-by":"crossref","unstructured":"Sumaroka A, Matsui R, Cideciyan AV, et al. Outer retinal changes including the ellipsoid zone band in Usher syndrome 1B due to MYO7A mutations. Invest Ophthalmol Vis Sci. 2016; 57: OCT253\u2013OCT261.","DOI":"10.1167\/iovs.15-18860"},{"key":"i1552-5783-59-11-4558-b37","doi-asserted-by":"crossref","unstructured":"Jacobson SG, McGuigan DB III, Sumaroka A, et al. Complexity of the Class B phenotype in autosomal dominant retinitis pigmentosa due to rhodopsin mutations. Invest Ophthalmol Vis Sci. 2016; 57: 4847\u20134858.","DOI":"10.1167\/iovs.16-19890"},{"key":"i1552-5783-59-11-4558-b38","doi-asserted-by":"crossref","unstructured":"Clarke G, Collins RA, Leavitt BR, et al. A one-hit model of cell death in inherited neuronal degenerations. Nature. 2000; 406: 195\u2013199.","DOI":"10.1038\/35018098"},{"key":"i1552-5783-59-11-4558-b39","doi-asserted-by":"crossref","unstructured":"Cideciyan AV, Swider M, Aleman TS, et al. ABCA4 disease progression and a proposed strategy for gene therapy. Hum Mol Genet. 2009; 18: 931\u2013941.","DOI":"10.1093\/hmg\/ddn421"},{"key":"i1552-5783-59-11-4558-b40","doi-asserted-by":"crossref","unstructured":"Hood DC, Birch DG. Abnormalities of the retinal cone system in retinitis pigmentosa. Vision Res. 1996; 36: 1699\u20131709.","DOI":"10.1016\/0042-6989(95)00246-4"},{"key":"i1552-5783-59-11-4558-b41","unstructured":"Jacobson SG, Cideciyan AV, Kemp CM, Sheffield VC, Stone EM. Photoreceptor function in heterozygotes with insertion or deletion mutations in the RDS gene. Invest Ophthalmol Vis Sci. 1996; 37: 1662\u20131674."},{"key":"i1552-5783-59-11-4558-b42","unstructured":"Milam AH, Li ZY, Cideciyan AV, Jacobson SG. Clinicopathologic effects of the Q64ter rhodopsin mutation in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1996; 37: 753\u2013765."},{"key":"i1552-5783-59-11-4558-b43","unstructured":"Jacobson SG, Cideciyan AV, Iannaccone A, et al. Disease expression of RP1 mutations causing autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2000; 41: 1898\u20131908."},{"key":"i1552-5783-59-11-4558-b44","doi-asserted-by":"crossref","unstructured":"Stockman A, Langendorfer M, Smithson HE, Sharpe LT. Human cone light adaptation: from behavioral measurements to molecular mechanisms. J Vis. 2006; 6: 1194\u20131213.","DOI":"10.1167\/6.11.5"},{"key":"i1552-5783-59-11-4558-b45","doi-asserted-by":"crossref","unstructured":"Herrera W, Aleman TS, Cideciyan AV, et al. Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene. Invest Ophthalmol Vis Sci. 2008; 49: 2651\u20132660.","DOI":"10.1167\/iovs.07-1505"},{"key":"i1552-5783-59-11-4558-b46","doi-asserted-by":"crossref","unstructured":"Birch DG, Anderson JL, Fish GE. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology. 1999; 106: 258\u2013268.","DOI":"10.1016\/S0161-6420(99)90064-7"},{"key":"i1552-5783-59-11-4558-b47","unstructured":"Bernstein SL, Wong P. Regional expression of disease-related genes in human and monkey retina. Mol Vis. 1998; 4: 24."},{"key":"i1552-5783-59-11-4558-b48","doi-asserted-by":"crossref","unstructured":"Sharon D, Blackshaw S, Cepko CL, Dryja TP. Profile of the genes expressed in the human peripheral retina, macula, and retinal pigment epithelium determined through serial analysis of gene expression (SAGE). Proc Natl Acad Sci U S A. 2002; 99: 315\u2013320.","DOI":"10.1073\/pnas.012582799"},{"key":"i1552-5783-59-11-4558-b49","doi-asserted-by":"crossref","unstructured":"Li M, Jia C, Kazmierkiewicz KL, et al. Comprehensive analysis of gene expression in human retina and supporting tissues. Hum Mol Genet. 2014; 23: 4001\u20134014.","DOI":"10.1093\/hmg\/ddu114"},{"key":"i1552-5783-59-11-4558-b50","doi-asserted-by":"crossref","unstructured":"Fahim AT, Bowne SJ, Sullivan LS, et al. Allelic heterogeneity and genetic modifier loci contribute to clinical variation in males with X-linked retinitis pigmentosa due to RPGR mutations. PLoS One. 2011; 6: e23021.","DOI":"10.1371\/journal.pone.0023021"},{"key":"i1552-5783-59-11-4558-b51","unstructured":"Appelbaum T, Becker D, Santana E, Aguirre GD. Molecular studies of phenotype variation in canine RPGR-XLPRA1. Mol Vis. 2016; 22: 319\u2013331."},{"key":"i1552-5783-59-11-4558-b52","doi-asserted-by":"crossref","unstructured":"Bebie H, Fankhauser F, Spahr J. Static perimetry: accuracy and fluctuations. Acta Ophthalmol (Copenh). 1976; 54: 339\u2013348.","DOI":"10.1111\/j.1755-3768.1976.tb01263.x"},{"key":"i1552-5783-59-11-4558-b53","doi-asserted-by":"crossref","unstructured":"Bebie H, Fankhauser F, Spahr J. Static perimetry: strategies. Acta Ophthalmol (Copenh). 1976; 54: 325\u2013338.","DOI":"10.1111\/j.1755-3768.1976.tb01262.x"},{"key":"i1552-5783-59-11-4558-b54","doi-asserted-by":"crossref","unstructured":"Young WO, Stewart WC, Hunt H, Crosswell H. Static threshold variability in the peripheral visual field in normal subjects. Graefes Arch Clin Exp Ophthalmol. 1990; 228: 454\u2013457.","DOI":"10.1007\/BF00927261"},{"key":"i1552-5783-59-11-4558-b55","doi-asserted-by":"crossref","unstructured":"Katz J, Sommer A. A longitudinal study of the age-adjusted variability of automated visual fields. Arch Ophthalmol. 1987; 105: 1083\u20131086.","DOI":"10.1001\/archopht.1987.01060080085033"},{"key":"i1552-5783-59-11-4558-b56","doi-asserted-by":"crossref","unstructured":"Heijl A, Lindgren G, Olsson J. Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol. 1987; 105: 1544\u20131549.","DOI":"10.1001\/archopht.1987.01060110090039"},{"key":"i1552-5783-59-11-4558-b57","doi-asserted-by":"crossref","unstructured":"Kim LS, McAnany JJ, Alexander KR, Fishman GA. Intersession repeatability of Humphrey perimetry measurements in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2007; 48: 4720\u20134724.","DOI":"10.1167\/iovs.07-0690"}],"container-title":["Investigative Opthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2702417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:57Z","timestamp":1791927057000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,9,4]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24931","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,12]]}}}